Literature DB >> 29577186

Antitumor Activity of Fascaplysin Derivatives on Glioblastoma Model In Vitro.

I A Lyakhova1, I S Bryukhovetsky2,3, I V Kudryavtsev2, Yu S Khotimchenko2,3, M E Zhidkov2, A V Kantemirov2.   

Abstract

Antitumor efficiency of fascaplysin synthetic derivatives (7-phenylfascaplysin, 3-chlorofascaplysin, 3-bromofascaplysin, and 10-bromofascaplysin) was compared out in vitro on C6 glioma cells. The cytotoxic efficiency of all tested compounds was higher than that of unsubstituted fascaplysin; 3-bromofascaplysin and 7-phenylfascaplysin exhibited the best capacity to kill glioma C6 cells. Apoptosis was the main mechanism of glioma cell death. The cytotoxic activity of these compounds increased with prolongation of exposure to the substance and increase of its concentration. Fascaplysin derivatives modified all phases of glioma cell vital cycle. The count of viable tumor cell in G0 phase remained minimum by the end of experiment under the effects of 3-bromofascaplysin and 7-phenylfascaplysin.

Entities:  

Keywords:  3-bromofascaplysin; apoptosis; cell cycle; fascaplysin; glia tumors

Mesh:

Substances:

Year:  2018        PMID: 29577186     DOI: 10.1007/s10517-018-4055-4

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  5 in total

1.  Anticancer Activity of Fascaplysin against Lung Cancer Cell and Small Cell Lung Cancer Circulating Tumor Cell Lines.

Authors:  Barbara Rath; Maximilian Hochmair; Adelina Plangger; Gerhard Hamilton
Journal:  Mar Drugs       Date:  2018-10-14       Impact factor: 5.118

2.  Total Syntheses and Preliminary Biological Evaluation of Brominated Fascaplysin and Reticulatine Alkaloids and Their Analogues.

Authors:  Maxim E Zhidkov; Polina A Smirnova; Oleg A Tryapkin; Alexey V Kantemirov; Yuliya V Khudyakova; Olesya S Malyarenko; Svetlana P Ermakova; Valeria P Grigorchuk; Moritz Kaune; Gunhild von Amsberg; Sergey A Dyshlovoy
Journal:  Mar Drugs       Date:  2019-08-25       Impact factor: 5.118

3.  Efficacy and Mechanism of Action of Marine Alkaloid 3,10-Dibromofascaplysin in Drug-Resistant Prostate Cancer Cells.

Authors:  Sergey A Dyshlovoy; Moritz Kaune; Jessica Hauschild; Malte Kriegs; Konstantin Hoffer; Tobias Busenbender; Polina A Smirnova; Maxim E Zhidkov; Ekaterina V Poverennaya; Su Jung Oh-Hohenhorst; Pavel V Spirin; Vladimir S Prassolov; Derya Tilki; Carsten Bokemeyer; Markus Graefen; Gunhild von Amsberg
Journal:  Mar Drugs       Date:  2020-12-01       Impact factor: 5.118

Review 4.  Marine Alkaloids: Compounds with In Vivo Activity and Chemical Synthesis.

Authors:  Paulo E S Munekata; Mirian Pateiro; Carlos A Conte-Junior; Rubén Domínguez; Asad Nawaz; Noman Walayat; Elena Movilla Fierro; José M Lorenzo
Journal:  Mar Drugs       Date:  2021-06-28       Impact factor: 5.118

5.  Study of Structure-Activity Relationships of the Marine Alkaloid Fascaplysin and Its Derivatives as Potent Anticancer Agents.

Authors:  Maxim E Zhidkov; Moritz Kaune; Alexey V Kantemirov; Polina A Smirnova; Pavel V Spirin; Maria A Sidorova; Sergey A Stadnik; Elena Y Shyrokova; Dmitry N Kaluzhny; Oleg A Tryapkin; Tobias Busenbender; Jessica Hauschild; Tina Rohlfing; Vladimir S Prassolov; Carsten Bokemeyer; Markus Graefen; Gunhild von Amsberg; Sergey A Dyshlovoy
Journal:  Mar Drugs       Date:  2022-03-02       Impact factor: 5.118

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.